![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Vernalis | LSE:VER | London | Ordinary Share | GB00B3Y5L754 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 6.17 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
15/5/2007 14:12 | That's a lot of sells and the price didn't budge! | ![]() fhmktg | |
15/5/2007 08:56 | Fellner has a reputation as a deal maker. Frova approval for PM migraine could trigger some action? | ![]() fhmktg | |
12/5/2007 12:59 | Thanks for info maiseymouse and Elgordo. This company has income streams which should grow with expected US drug approval in near future. Nice to see a bio company with established products in the market and a good flow of drugs in research stage. | penbroker | |
12/5/2007 10:29 | Tipped as "gamble of the week" by Paul Hill in this week's MoneyWeek. Concludes with reminder of PiperJaffray and Goldmans Sachs price targets of 123p and 86p, and that Vernalis "could become a takeover target". | ![]() elgordo | |
08/5/2007 12:12 | A bit of support from bridgewell Granted it is looking towards the Parkinson's drugs, but I think we may see a tick up ahead of the Frova announcement. | maiseymouse | |
08/5/2007 10:09 | am not in the UK...forgot you guys had a holiday..... : ) | thecynical1 | |
07/5/2007 10:24 | We are closed today! | ![]() fhmktg | |
07/5/2007 08:32 | morning all....if there is anyone out there that is.....has anyone any idea why the offer is so far out ? or is my monitor playing games? I am seeing 83p on the offer.....are the MMs expecting something ? | thecynical1 | |
24/4/2007 14:05 | SPT (Spirent Communications plc) is also thought to be considering de-listing from the American exchanges due to the expense in time and money for very extra benefit. The Sarbanes-Oxley Act, although well intentioned in terms of making financial matters visible, in my experience appears to have had the opposite effect. This might well be due to other factors which I have not really considered. | mmamuk2 | |
24/4/2007 11:22 | I personally think a delisting from the Nasdaq is a good thing and I have always been against it for Small Biotechs. It is a huge amount of expense in time and money for very little gain. It would be interesting to see exactly how much has been traded in total since listing. Back to business imo. | ![]() vow | |
23/4/2007 16:57 | Indeed. Excellent news. Fingers crossed for Frova! | iancath | |
23/4/2007 14:20 | Thanks el gordo! | ![]() fhmktg | |
23/4/2007 11:19 | The rise continues. Does anyone have any idea if there's something behind it? I've searched around and come up with nothing yet. | iancath | |
20/4/2007 12:04 | Anything in the Investors Chronicle today? Could be early optimism about Frova for menstrual migraine - though not now due before August. | ![]() fhmktg | |
20/4/2007 11:53 | why the rise ??are there any reports due for publication. | ![]() barrie16 | |
20/4/2007 11:50 | chatterbox That is right have started on the UP this morning and volume has push the share to 5p up now Most likely was due to a late trade 16.40pm for 56K share at middle price | master rsi | |
20/4/2007 11:44 | nice little rise today | ![]() chatterbox | |
11/4/2007 15:02 | Up 11% in early trading on NASDQ - some promotional activity over the pond? | ![]() fhmktg | |
10/4/2007 23:27 | YES the climb continues though in a small pace | master rsi | |
03/4/2007 22:35 | thanks master rsi, I believe this will climb slowly and am in for the long term but currently 40% down. | ![]() 4screws | |
03/4/2007 13:38 | Slowly going higher again today 10 days chart | master rsi | |
02/4/2007 15:06 | Other Parkinson's Drugs Not Affected Permax belongs to a class of drugs called dopamine agonists. Today's action doesn't affect any other dopamine agonists or other types of Parkinson's disease drugs. It clearly states that other dopamine agonists are unaffected by the withdrawal and the market has reacted positively to the news. | iancath | |
02/4/2007 13:07 | I am not sure how this drug sits vis-a-vis Apokyn.. any takers? Maybe a chance for more sales... | rfinance |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions